Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023

25.04.2023 | Other Articles

Salvage Endoscopic Nasopharyngectomy for Locally Recurrent T1 and T2 Nasopharyngeal Carcinoma

verfasst von: Neizekhotuo Brian Shunyu, Zareen Lynrah, Jayanta Medhi, Hanifa Aktar, Judita Syiemlieh, Nari Lyngdoh

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Assessment of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma (rNPC). This is a retrospective study of ten rNPC who underwent salvage endoscopic nasopharyngectomy. Recurrent status for each recurrence was determined before surgery and only recurrent T1 (rT1) and recurrent T2 (rT2) were taken up for surgery after review with radiation oncology colleagues. There were seven rT2 and three rT1 patients. Two patients have undergone simultaneous radical neck dissection (RND) together with endoscopic nasopharyngectomy for associated neck nodes. Outcome of the study was done in turn of disease free, disease residual and disease recurrence. Locally disease free and overall survival rates were 40% (4/10) and 50% (5/10) respectively. Locally disease free till the last follow up was achieved in 4 patients while one patient is on palliative chemotherapy post-surgery for locally positive disease for the last three years. Of the four patients that are locally disease free, two patients received chemoradiation (CTRT) post-surgery while two patients only underwent endoscopic nasopharyngectomy for rT1. There were no any major operative complications except nasal crusting. Recurrent T1 and T2 can be manage with endoscopic nasopharyngectomy and post-surgery ctrt should be given in feasible patients. To detect early recurrent and improve the survival, regular endoscopic follow up is needed.
Literatur
1.
2.
Zurück zum Zitat Wee JT, Ha TC, Loong SL, Qian CN (2010) Is nasopharyngeal carcinoma really a “Cantonese Cancer”? Chin J Cancer 29(5):517–526CrossRefPubMed Wee JT, Ha TC, Loong SL, Qian CN (2010) Is nasopharyngeal carcinoma really a “Cantonese Cancer”? Chin J Cancer 29(5):517–526CrossRefPubMed
3.
Zurück zum Zitat Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765–1777CrossRefPubMed Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765–1777CrossRefPubMed
4.
Zurück zum Zitat Hirayama T (1978) Descriptive and analytic epidemiology of nasopharyngeal carcinoma. In: De The G, Ito Y (eds) Nasopharyngeal carcinoma: etiology and control, vol 20. IARC Scientific Publications, Lyon, pp 167–189 Hirayama T (1978) Descriptive and analytic epidemiology of nasopharyngeal carcinoma. In: De The G, Ito Y (eds) Nasopharyngeal carcinoma: etiology and control, vol 20. IARC Scientific Publications, Lyon, pp 167–189
5.
Zurück zum Zitat Kataki AC, Simons MJ, Das AK, Sharma K, Mehra NK (2011) Nasopharyngeal carcinoma in the Northeastern states of India. Chin J Cancer 30(2):106–113CrossRefPubMedPubMedCentral Kataki AC, Simons MJ, Das AK, Sharma K, Mehra NK (2011) Nasopharyngeal carcinoma in the Northeastern states of India. Chin J Cancer 30(2):106–113CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sharma TD, Singh TT, Laishram RS, Sharma LDC, Sunita AK, Imchen LT (2011) Nasopharyngeal carcinoma—a clinico-pathological study in a Regional Cancer Centre of Northeastern India. Asian Pac J Cancer Prev 12(6):1583–1587 PubMed Sharma TD, Singh TT, Laishram RS, Sharma LDC, Sunita AK, Imchen LT (2011) Nasopharyngeal carcinoma—a clinico-pathological study in a Regional Cancer Centre of Northeastern India. Asian Pac J Cancer Prev 12(6):1583–1587 PubMed
7.
Zurück zum Zitat Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Clin Oncol 16(4):1310–1317. https://doi.org/10.1200/JCO.1998.16.4.1310CrossRef Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Clin Oncol 16(4):1310–1317. https://​doi.​org/​10.​1200/​JCO.​1998.​16.​4.​1310CrossRef
8.
Zurück zum Zitat Chan ATC, Leung SF, Ngan RKC, Teo PML, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TSK, Yau S, Yuen KT, Mo FKF, Lai MMP, Ma BBY, Kam MKM, Leung TWT, Johnson PJ, Choi PHK, Zee BCY (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97(7):536–539. https://doi.org/10.1093/jnci/dji084CrossRefPubMed Chan ATC, Leung SF, Ngan RKC, Teo PML, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TSK, Yau S, Yuen KT, Mo FKF, Lai MMP, Ma BBY, Kam MKM, Leung TWT, Johnson PJ, Choi PHK, Zee BCY (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97(7):536–539. https://​doi.​org/​10.​1093/​jnci/​dji084CrossRefPubMed
9.
Zurück zum Zitat Sarma G, Paul M, Nath J, Medhi PP, Bhattacharyya M, Kalita AK (2022) Clinical outcomes and prognostic factors of locally advanced nasopharyngeal cancer treated with intensity modulated radiotherapy: first experience report from Northeast India. Indian J Otolaryngol Head Neck Surg 74:5964–5973CrossRefPubMed Sarma G, Paul M, Nath J, Medhi PP, Bhattacharyya M, Kalita AK (2022) Clinical outcomes and prognostic factors of locally advanced nasopharyngeal cancer treated with intensity modulated radiotherapy: first experience report from Northeast India. Indian J Otolaryngol Head Neck Surg 74:5964–5973CrossRefPubMed
13.
Zurück zum Zitat King WW, Ku PK, Mok CO, Teo PM (2000) Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 22(3):215–222CrossRefPubMed King WW, Ku PK, Mok CO, Teo PM (2000) Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 22(3):215–222CrossRefPubMed
14.
Zurück zum Zitat Hsu MM, Hong RL, Ting LL, Ko JY, Sheen TS, Lou PJ (2001) Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases. Arch Otolaryngol Head Neck Surg 127(7):798–802PubMed Hsu MM, Hong RL, Ting LL, Ko JY, Sheen TS, Lou PJ (2001) Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases. Arch Otolaryngol Head Neck Surg 127(7):798–802PubMed
15.
Zurück zum Zitat Vlantis AC, Chan HS, Tong MC, Yu BK, Kam MK, van Hasselt CA (2011) Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors. Head Neck 33(8):1126–1131CrossRefPubMed Vlantis AC, Chan HS, Tong MC, Yu BK, Kam MK, van Hasselt CA (2011) Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors. Head Neck 33(8):1126–1131CrossRefPubMed
16.
Zurück zum Zitat Vlantis AC, Lee DL, Wong EW, Chow SM, Ng SK, Chan JY (2017) Endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: a case series, literature review, and pooled analysis. Int Forum Allergy Rhinol 7(4):425–432CrossRefPubMed Vlantis AC, Lee DL, Wong EW, Chow SM, Ng SK, Chan JY (2017) Endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: a case series, literature review, and pooled analysis. Int Forum Allergy Rhinol 7(4):425–432CrossRefPubMed
17.
Zurück zum Zitat Ko JY, Wang CP, Ting LL, Yang TL, Tan CT (2009) Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma. Head Neck 31(10):1309–1315CrossRefPubMed Ko JY, Wang CP, Ting LL, Yang TL, Tan CT (2009) Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma. Head Neck 31(10):1309–1315CrossRefPubMed
18.
Zurück zum Zitat Chen MY, Wen WP, Guo X et al (2009) Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. Laryngoscope 119(3):516–522CrossRefPubMed Chen MY, Wen WP, Guo X et al (2009) Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. Laryngoscope 119(3):516–522CrossRefPubMed
19.
Zurück zum Zitat Emanuelli E, Albu S, Cazzador D, Pedruzzi B, Babighian G, Martini A (2014) Endoscopic surgery for recurrent undifferentiated nasopharyngeal carcinoma. J Craniofac Surg 25(3):1003–1008CrossRefPubMed Emanuelli E, Albu S, Cazzador D, Pedruzzi B, Babighian G, Martini A (2014) Endoscopic surgery for recurrent undifferentiated nasopharyngeal carcinoma. J Craniofac Surg 25(3):1003–1008CrossRefPubMed
20.
Zurück zum Zitat Hsu NI, Shen PH, Chao SS, Ong YK, Li CS (2014) En bloc resection concept for endoscopic endonasal nasopharyngectomy: surgical anatomy and outcome. Chin Med J 127(16):2934–2939PubMed Hsu NI, Shen PH, Chao SS, Ong YK, Li CS (2014) En bloc resection concept for endoscopic endonasal nasopharyngectomy: surgical anatomy and outcome. Chin Med J 127(16):2934–2939PubMed
21.
Zurück zum Zitat Wong EHC, Liew YT, Loong SP, Prepageran N (2020) Five-year survival data on the role of endoscopic endonasal nasopharyngectomy in advanced recurrent rT3 and rT4 nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 129(3):287–293CrossRefPubMed Wong EHC, Liew YT, Loong SP, Prepageran N (2020) Five-year survival data on the role of endoscopic endonasal nasopharyngectomy in advanced recurrent rT3 and rT4 nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 129(3):287–293CrossRefPubMed
22.
Zurück zum Zitat Zou X, Han F, Ma WJ et al (2015) Salvage endoscopic nasopharyngectomy and intensitymodulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma. Head Neck 37(8):1108–1115CrossRefPubMed Zou X, Han F, Ma WJ et al (2015) Salvage endoscopic nasopharyngectomy and intensitymodulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma. Head Neck 37(8):1108–1115CrossRefPubMed
23.
Zurück zum Zitat Thamboo A, Petal VS, Hwang PH (2021) 5- year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal cancer. J Otolaryngol Head Neck Surg 50:12CrossRefPubMedPubMedCentral Thamboo A, Petal VS, Hwang PH (2021) 5- year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal cancer. J Otolaryngol Head Neck Surg 50:12CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hua YJ, Han F, Lu LX et al (2012) Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 48(18):3422–3428CrossRefPubMed Hua YJ, Han F, Lu LX et al (2012) Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 48(18):3422–3428CrossRefPubMed
25.
Zurück zum Zitat Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ (2012) Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 83(2):676–683CrossRefPubMed Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ (2012) Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 83(2):676–683CrossRefPubMed
26.
Zurück zum Zitat Fee WE Jr, Moir MS, Choi EC, Goffinet D (2002) Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg 128(3):280–284CrossRefPubMed Fee WE Jr, Moir MS, Choi EC, Goffinet D (2002) Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg 128(3):280–284CrossRefPubMed
27.
Zurück zum Zitat You R, Zou X, Hua YJ et al (2015) Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma - a case-matched comparison. Radiother Oncol 115(3):399–406CrossRefPubMed You R, Zou X, Hua YJ et al (2015) Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma - a case-matched comparison. Radiother Oncol 115(3):399–406CrossRefPubMed
Metadaten
Titel
Salvage Endoscopic Nasopharyngectomy for Locally Recurrent T1 and T2 Nasopharyngeal Carcinoma
verfasst von
Neizekhotuo Brian Shunyu
Zareen Lynrah
Jayanta Medhi
Hanifa Aktar
Judita Syiemlieh
Nari Lyngdoh
Publikationsdatum
25.04.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-03773-7

Weitere Artikel der Ausgabe 3/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.